Skip to main content
. 2017 Oct 5;36(17):1658–1667. doi: 10.1200/JCO.2017.73.7379

Fig A1.

Fig A1.

Study schema for phase II. ECOG, Eastern Cooperative Oncology Group; irRC, immune-related response criteria; IV, intravenous; ORR, objective response rate; OS, overall survival; PD-1, programmed death-1; PFS, progression-free survival; PFU, plaque-forming unit; R, randomization. (*) irRC described in Wolchok et al.14